6949 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Pell Bio-Med Technology Co., Ltd. operates as a biotechnology company. It provides cell culture technology development, clinical application of cell therapy and other services. The company was founded on March 30, 2017 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6949 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company